Your browser doesn't support javascript.
loading
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Chen, Li-Shiun; Baker, Timothy B; Miller, J Philip; Bray, Michael; Smock, Nina; Chen, Jingling; Stoneking, Faith; Culverhouse, Robert C; Saccone, Nancy L; Amos, Christopher I; Carney, Robert M; Jorenby, Douglas E; Bierut, Laura J.
Afiliação
  • Chen LS; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Baker TB; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, Missouri, USA.
  • Miller JP; Division of General Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Bray M; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Smock N; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Chen J; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Stoneking F; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Culverhouse RC; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
  • Saccone NL; John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
  • Amos CI; Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri, USA.
  • Carney RM; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, USA.
  • Jorenby DE; Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
  • Bierut LJ; Department of Medicine, Baylor College of Medicine, Institute for Clinical and Translational Research, Houston, Texas, USA.
Clin Pharmacol Ther ; 108(6): 1315-1325, 2020 12.
Article em En | MEDLINE | ID: mdl-32602170
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Abandono do Hábito de Fumar / Agonistas Nicotínicos / Dispositivos para o Abandono do Uso de Tabaco / Vareniclina / Variantes Farmacogenômicos / Fumantes / Agentes de Cessação do Hábito de Fumar / Proteínas do Tecido Nervoso / Nicotina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Abandono do Hábito de Fumar / Agonistas Nicotínicos / Dispositivos para o Abandono do Uso de Tabaco / Vareniclina / Variantes Farmacogenômicos / Fumantes / Agentes de Cessação do Hábito de Fumar / Proteínas do Tecido Nervoso / Nicotina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos